BPC-157, which stands for Body Protection Compound-157, is a powerful regenerative sequence of amino acids
The National Institute on Drug Abuse (NIDA) is currently funding randomized clinical studies to assess whether GLP-1 medications could help treat opioid and stimulant use disorders as well
Lixisenatide, a structurally modified derivative of exendin-4, addresses some of these limitations by offering a longer half-life of approximately 3 h, thereby permitting once-daily dosing (Leon et al., 2017)
This is why weight loss naturally slows over time even when youre doing everything right
Every 10% reduction in body weight significantly decreases GERD symptoms and may even eliminate the need for acid-suppressing medication
For a 70 kg person, that yields 1.05 to 2.1 mg per day, consistent with the flat-dose ranges below